Get the Stockscreener App
0.6405
4.42%
-0.0296
After Hours:
.59
-0.0505
-7.88%
Sol Gel Technologies Ltd Stock (SLGL) Latest News
Acne Market Predicted to See Upsurge Through 2032, Highlights - openPR
Palmoplantar Keratoderma Clinical and Non-Clinical Studies, - openPR
Personalis (PSNL) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
SLGL Gears Up to Report Q4 Earnings: Here's What You Should Know - MSN
Supernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Sol-Gel Technologies Schedules Shareholder Meeting to Vote on Key Proposals - TipRanks
Basal Cell Nevus Syndrome Treatment Market Size in the 7MM - openPR
Biotech Stocks Facing FDA Decision In August 2021 - RTTNews
Sol-Gel Technologies Ltd (SLGL) Shares Decline Despite Market Challenges - The News Heater
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Not Doing Enough For Some Investors As Its Shares Slump 51% - Simply Wall St
Is Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Constellium SE’s (CSTM) Stock: A -3.86% Simple Moving Average for the Past 20 Days - The News Heater
Tronox Holdings plc (TROX): A Technical Analysis - The News Heater
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease - Yahoo Finance
Rosacea Clinical Trials Analysis 2025: EMA, PDMA, FDA - openPR
Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects - Yahoo Finance
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Acne Vulgaris Market Size to Reach USD 10.4 Billion by 2035, with a Growth Rate (CAGR) of 3.33% during 2025-2035 - BioSpace
Rosacea Pipeline Analysis, Clinical Trials, EMA, PDMA, FDA - openPR
Actinic Keratosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail
Acne Vulgaris Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, MOA, ROA by DelveInsight | Dermata Therapeutics, AstraZeneca, Novartis, UCB Pharma, Incyte Inc., Galderma - The Globe and Mail
Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews
DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times
Acne Vulgaris Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Is SolGel Technologies (SLGL) a Great Value Stock Right Now? - Yahoo Finance
There's Reason For Concern Over Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Massive 209% Price Jump - Simply Wall St
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket - Benzinga
United States shares higher at close of trade; Dow Jones Industrial Average up 0.16% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16% - Investing.com
SLGL Stock Touches 52-Week High at $1.65 Amid Market Fluctuations - Investing.com
The Next-Generation Solar Cell Market Set to Reach $12.91 Billion by 2031. - openPR
Rosacea Treatment Market Growth in Future Scope 2024-2031 | - openPR
Solar Lighting System Market Trends and Future Opportunities 2024-2032 - openPR
Acne Vulgaris Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR
Global Solar Street Lighting Market to Reach USD 12.38 Billion by 2029, Growing at a CAGR of 14.5% - openPR
Revolutionary Solar Lighting Innovations for 2024 - openPR
Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Sol-Gel receives Nasdaq compliance extension By Investing.com - Investing.com Nigeria
Sol-Gel Technologies Reports Strong Q3 2024 Results - TipRanks
SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Sol-Gel receives Nasdaq compliance extension - Investing.com India
SEALSQ updates on minimum bid price non-compliance - MSN
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement - The Manila Times
Microlise Group Reassures Investors After Cyber Incident - MSN
Solar Lighting System Market Current Status and Future Prospects till 2031 - openPR
Smudge-Free Innovations: 2024 Global Market Insights on Anti-Fingerprint Coatings In The Latest Report - WhaTech
GlobalData Executes Share Buyback Program - MSN
Sol Gel Tech earnings beat by $0.04, revenue topped estimates - Investing.com South Africa
Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Form 424B3 Sol-Gel Technologies - StreetInsider.com
SEC Form 424B3 filed by Sol-Gel Technologies Ltd. - Quantisnow
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - The Manila Times
Sol-Gel Technologies Q3 Revenue Surges to $5.4M, Narrows Losses Amid Strategic Growth | SLGL Stock News - StockTitan
Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline - Yahoo Finance
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):